One of the strategic objectives of the 2011–2020 Global Vaccine Action Plan is for the
benefits of immunisation to be equitably extended to all people. This approach …

Despite recent advances in the field of allogeneic hematopoietic stem cell transplantation
(HSCT), viral infections are still a major complication during the period of immune …

Donor-derived adoptive T-cell therapy is a safe and effective treatment of viral infection
posttransplant, but it is limited by donor serostatus and availability and by its personalized …

In spite of an increasing array of investigations, the relationships between viral infections
and allogeneic hematopoietic stem cell transplantation (HSCT) are still controversial, and …

While progress has been made in the treatment of both hematologic cancers and solid
tumors, chemorefractory or relapsed disease often portends a dismal prognosis, and …

Immunocompromised host section: Adoptive T-cell therapy for... : Current Opinion in
Infectious Diseases Immunocompromised host section: Adoptive T-cell therapy for dsDNA …

Viral infections are common and are potentially life-threatening in patients with moderate to
severe primary immunodeficiency disorders. Because T-cell immunity contributes to the …

PURPOSE BK virus-associated hemorrhagic cystitis (BKV-HC) is a common complication of
allogenic hematopoietic stem cell transplantation (AHSCT), particularly in recipients of …

Immunotherapy with antigen-specific T cells is a promising, targeted therapeutic option for
patients with cancer as well as for immunocompromised patients with virus infections. In this …

Hematopoietic stem cell transplantation (HSCT) donor–generated virus-specific T cells
(VSTs) can provide effective treatment for viral infection post-HSCT but are not readily …